Yilmaz, DÜstündag, GBüyükçam, ASali, EÇelik, ÜAvcu, GBelet, NTaskin, EÇDemir, SÖBirbilen, AZKiliç, ÖAkcan, ÖMYilmaz, ATKocabas, BAHatipoglu, NKarbuz, AÇakir, DSütçü, MAygün, FDÇelik, TSen, SBDalgiç, NÜmit, ZKara, SSÖncel, EKBolat, AÇil, MKTuran, CGuzin, AÇTopal, SBesli, GEDogan, GSahin, SAkin, FBildirici, YDayar, GTSari, EEIsançli, DKKara, MÖnal, PAylaç, HLüleci, DYasar, BDede, EÇaglar, AAkova, STurgut, EAÖzkaya, PYGülmez, TKUlusoy, EDuyu, MKara, YÇeliktas, HTekeli, OÇaglar, FGül, DCebeci, SOBattal, FBal, AAygün, EUysalol, MArslan, GÖzkavakli, AKizil, MCYazar, AAygün, FSomer, AKuyucu, NDinleyici, EÇKara, A2024-07-182024-07-180340-61991432-1076http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10929This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs.EnglishHOSPITALIZED-PATIENTSCHILDRENDISEASEA snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from TurkeyArticle